Defining clinically significant prostate cancer on the basis of pathological findings-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defining clinically significant prostate cancer on the basis of pathological findings

Published:2018-12-18 Issue:1 Volume:74 Page:135-145
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Matoso Andres¹^ORCID,Epstein Jonathan I¹^ORCID

Affiliation:

1. Departments of Pathology, Urology and Oncology; Johns Hopkins Medical Institutions; Baltimore MD USA

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13712/fullpdf

Reference88 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. Patterns of progression in prostate cancer;McNeal;Lancet,1986

3. Latent carcinoma of the prostate;Franks;J. Pathol. Bacteriol.,1954

4. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage t1c) prostate cancer;Epstein;JAMA,1994

5. Comorbidity and mortality results from a randomized prostate cancer screening trial;Crawford;J. Clin. Oncol.,2011

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing;The Prostate;2024-07-25

2. Predicting the Diagnosis of Prostate Cancer with a Novel Blood-Based Biomarker: Comparison of Its Performance with Prostate-Specific Antigen;Cancers;2024-07-23

3. A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer;BJU International;2024-07-14

4. Early economic evaluation of magnetic resonance imaging for prostate cancer detection in primary care;BJUI Compass;2024-07-10

5. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer;Annals of Internal Medicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3